Position in ARGX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$469,451
+$99,945 QoQ
Shares Held
506
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#307
of 504 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Keudell/Morrison Wealth Management holds $2,313,445 across 6 Biotechnology names. ARGX ranks #2 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYMR |
Kymera Therapeutics, Inc.
|
5,215 | $598,004 | |
| 2 | ARGX |
Argenx SE
This page
|
506 | $469,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
582 | $362,900 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,359 | $327,478 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
612 | $303,998 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
6,450 | $251,614 |
All Filings in ARGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $469,451 | 506 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $369,506 | 506 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $425,520 | 506 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $294,351 | 534 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $299,483 | 506 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $311,805 | 507 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $206,532 | 381 | Shares | Sole | 2024-10-31 | |
| No filing history on record for this holder in this stock. | ||||||